Results 111 to 120 of about 1,206 (138)

Daratumumab-based regimens versus CyBorD in newly diagnosed patients with AL amyloidosis and IIIb cardiac stage: A matched case-control study. [PDF]

open access: yesHemasphere
Bellofiore C   +11 more
europepmc   +1 more source

Ultrasound-guided adjunct to endovascular treatment of long-segment femoropopliteal chronic total occlusion. [PDF]

open access: yesEur J Med Res
Wang DS   +8 more
europepmc   +1 more source

Assessing the feasibility of the Virtual Reality Education and Acceptance Protocol among baseball and softball players. [PDF]

open access: yesPLoS One
Lewellen JA   +7 more
europepmc   +1 more source

Juvenile dermatomyositis in Oman: clinical patterns and disease trajectory from a National cohort. [PDF]

open access: yesPediatr Rheumatol Online J
Abdwani R   +5 more
europepmc   +1 more source

Identifying Maternal Conditions Leading to Gabapentinoid Prescriptions in Pregnancy Using Electronic Health Records from Six European Countries: A Contribution from the IMI ConcePTION Project. [PDF]

open access: yesDrug Saf
Beau AB   +23 more
europepmc   +1 more source

Potent Inhibition of Cdc2 Kinase Activity by the Flavonoid L86-8275

open access: closedBiochemical and Biophysical Research Communications, 1994
L86-8275 [(-) cis-5,7-dihydroxy-2-(2-chlorophenyl)-8[4-(3-hydroxy-1- methyl)-piperidinyl]-4H-benzopyran-4-one] directly inhibits immunoprecipitated Cdc2 kinase activity from G2/M synchronized MDA-MB-468 breast carcinoma cells and is at least 250-fold more potent than either quercetin or genistein.
M D, Losiewicz   +4 more
  +11 more sources

Home - About - Disclaimer - Privacy